Nurses, APPs Key to AE Management as T-Cell Engagers Move Into Solid Tumors
As T-cell engager therapies expand from hematologic malignancies into solid tumors, oncology nurses and advanced practice providers (APPs) play a critical role in managing an evolving spectrum of immune-related toxicities, experts reported at the 2025 Immune Cell Effector Therapies (ICE-T) Conference. Daniel Carrizosa, MD, MS, a physician at Atrium Health Levine Cancer Institute and associate…